Jennifer Le1, Brenda Poindexter2,3, Janice E Sullivan4, Matthew Laughon5, Paula Delmore6, Martha Blackford7, Ram Yogev8, Laura P James9, Chiara Melloni10,11, Barrie Harper11, Jeff Mitchell12, Daniel K Benjamin10,11, Felix Boakye-Agyeman10,11, Michael Cohen-Wolkowiez10,11. 1. Skaggs School of Pharmacy, University of California, San Diego, San Diego, California. 2. Indiana University School of Medicine, Indianapolis, Indiana. 3. Cincinnati Children's, Cincinnati, Ohio. 4. Kosair Charities Pediatric Clinical Research Unit, Norton Children's Hospital, University of Louisville, Louisville, Kentucky. 5. University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 6. Wesley Medical Center, Wichita, Kansas. 7. Akron Children's Hospital, Akron, Ohio. 8. Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois. 9. University of Arkansas for Medical Sciences, Arkansas Children's Hospital at Little Rock, Little Rock, Arkansas. 10. Duke University Medical Center. 11. Duke Clinical Research Institute, Durham, North Carolina. 12. The EMMES Corporation, Rockville, Maryland.
Abstract
BACKGROUND: Dried blood spot (DBS) is a practical sampling strategy for pharmacokinetic studies in neonates. The utility of DBS to determine the population pharmacokinetics (pop-PK) of ampicillin, as well as accuracy versus plasma samples, was evaluated. METHODS: An open-label, multicenter, opportunistic, prospective study was conducted in neonates. Ampicillin concentrations from plasma and DBS (CONCPlasma and CONCDBS) were measured by liquid chromatographic tandem mass spectrometry and analyzed using pop-PK and statistical (including transformation) approaches. RESULTS: A total of 29 paired plasma and DBS samples from 18 neonates were analyzed. The median (range) gestational age and postnatal age were 37 (27-41) weeks and 8 (1-26) days, respectively. The geometric mean of CONCDBS to CONCPlasma ratio was 0.56. Correlation analysis demonstrated strong association between CONCPlasma and CONCDBS (r = 0.902, analysis of variance P < 0.001). Using linear regression transformation, the estimated CONCPlasma (eCONCPlasma) was derived using (CONCDBS - 3.223)/0.51. The median bias and geometric mean ratio improved to -11% and 0.88 (Wilcoxon signed-rank test, P < 0.001), respectively, when comparing eCONCPlasma to CONCPlasma. Furthermore, using pop-PK modeling, the median bias (interquartile range) for clearance and individual predicted concentrations improved to 8% (-11 to 50) and -8% (-34 to 11), respectively, when eCONCPlasma was used. CONCLUSIONS: After transformation, DBS sampling accurately predicted ampicillin exposure in neonates.
BACKGROUND: Dried blood spot (DBS) is a practical sampling strategy for pharmacokinetic studies in neonates. The utility of DBS to determine the population pharmacokinetics (pop-PK) of ampicillin, as well as accuracy versus plasma samples, was evaluated. METHODS: An open-label, multicenter, opportunistic, prospective study was conducted in neonates. Ampicillin concentrations from plasma and DBS (CONCPlasma and CONCDBS) were measured by liquid chromatographic tandem mass spectrometry and analyzed using pop-PK and statistical (including transformation) approaches. RESULTS: A total of 29 paired plasma and DBS samples from 18 neonates were analyzed. The median (range) gestational age and postnatal age were 37 (27-41) weeks and 8 (1-26) days, respectively. The geometric mean of CONCDBS to CONCPlasma ratio was 0.56. Correlation analysis demonstrated strong association between CONCPlasma and CONCDBS (r = 0.902, analysis of variance P < 0.001). Using linear regression transformation, the estimated CONCPlasma (eCONCPlasma) was derived using (CONCDBS - 3.223)/0.51. The median bias and geometric mean ratio improved to -11% and 0.88 (Wilcoxon signed-rank test, P < 0.001), respectively, when comparing eCONCPlasma to CONCPlasma. Furthermore, using pop-PK modeling, the median bias (interquartile range) for clearance and individual predicted concentrations improved to 8% (-11 to 50) and -8% (-34 to 11), respectively, when eCONCPlasma was used. CONCLUSIONS: After transformation, DBS sampling accurately predicted ampicillin exposure in neonates.
Authors: K C Wade; D Wu; D A Kaufman; R M Ward; D K Benjamin; J E Sullivan; N Ramey; B Jayaraman; K Hoppu; P C Adamson; M R Gastonguay; J S Barrett Journal: Antimicrob Agents Chemother Date: 2008-09-22 Impact factor: 5.191
Authors: Christopher Evans; Mark Arnold; Peter Bryan; Jeffrey Duggan; Christopher A James; Wenkui Li; Steve Lowes; Luca Matassa; Timothy Olah; Philip Timmerman; Xiaomin Wang; Enaksha Wickremsinhe; John Williams; Eric Woolf; Patricia Zane Journal: AAPS J Date: 2014-12-09 Impact factor: 4.009
Authors: Teresa L Parsons; Mark A Marzinke; Thuy Hoang; Erin Bliven-Sizemore; Marc Weiner; William R Mac Kenzie; Susan E Dorman; Kelly E Dooley Journal: Antimicrob Agents Chemother Date: 2014-09-02 Impact factor: 5.191
Authors: Victor R De Jesus; X Kate Zhang; Joan Keutzer; Olaf A Bodamer; Adolf Mühl; Joseph J Orsini; Michele Caggana; Robert F Vogt; W Harry Hannon Journal: Clin Chem Date: 2008-11-06 Impact factor: 8.327
Authors: Jennifer Le; John S Bradley; William Murray; Gale L Romanowski; Tu T Tran; Natalie Nguyen; Susan Cho; Stephanie Natale; Ivilynn Bui; Tri M Tran; Edmund V Capparelli Journal: Pediatr Infect Dis J Date: 2013-04 Impact factor: 2.129
Authors: D H Vu; M S Bolhuis; R A Koster; B Greijdanus; W C M de Lange; R van Altena; J R B J Brouwers; D R A Uges; J W C Alffenaar Journal: Antimicrob Agents Chemother Date: 2012-08-27 Impact factor: 5.191
Authors: Tavey Dorofaeff; Rossella M Bandini; Jeffrey Lipman; Daynia E Ballot; Jason A Roberts; Suzanne L Parker Journal: Clin Ther Date: 2016-08-17 Impact factor: 3.393
Authors: Michael Cohen-Wolkowiez; Daniele Ouellet; P Brian Smith; Laura P James; Ashley Ross; Janice E Sullivan; Michele C Walsh; Arlene Zadell; Nancy Newman; Nicole R White; Angela D M Kashuba; Daniel K Benjamin Journal: Antimicrob Agents Chemother Date: 2012-01-17 Impact factor: 5.191
Authors: Adriana Tremoulet; Jennifer Le; Brenda Poindexter; Janice E Sullivan; Matthew Laughon; Paula Delmore; Andrea Salgado; Sandy Ian-U Chong; Chiara Melloni; Jamie Gao; Daniel K Benjamin; Edmund V Capparelli; Michael Cohen-Wolkowiez Journal: Antimicrob Agents Chemother Date: 2014-03-10 Impact factor: 5.938
Authors: Daniel Gonzalez; Debra L Palazzi; Leena Bhattacharya-Mithal; Amira Al-Uzri; Laura P James; John Bradley; Natalie Neu; Theresa Jasion; Christoph P Hornik; P Brian Smith; Daniel K Benjamin; Kara Keedy; Prabhavathi Fernandes; Michael Cohen-Wolkowiez Journal: Antimicrob Agents Chemother Date: 2016-03-25 Impact factor: 5.938
Authors: Tom C Zwart; Sumit R M Gokoel; Paul J M van der Boog; Johan W de Fijter; Dina M Kweekel; Jesse J Swen; Henk-Jan Guchelaar; Dirk Jan A R Moes Journal: Br J Clin Pharmacol Date: 2018-10-15 Impact factor: 4.335